128 reports of this reaction
2.5% of all CEFUROXIME SODIUM reports
#2 most reported adverse reaction
HYPERSENSITIVITY is the #2 most commonly reported adverse reaction for CEFUROXIME SODIUM. There are 128 FDA adverse event reports linking CEFUROXIME SODIUM to HYPERSENSITIVITY. This represents approximately 2.5% of all 5,150 adverse event reports for this drug.
Patients taking CEFUROXIME SODIUM who experience hypersensitivity should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HYPERSENSITIVITY is a less commonly reported adverse event for CEFUROXIME SODIUM, but still significant enough to appear in the safety profile.
In addition to hypersensitivity, the following adverse reactions have been reported for CEFUROXIME SODIUM:
The following drugs have also been linked to hypersensitivity in FDA adverse event reports:
HYPERSENSITIVITY has been reported as an adverse event in 128 FDA reports for CEFUROXIME SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
HYPERSENSITIVITY accounts for approximately 2.5% of all adverse event reports for CEFUROXIME SODIUM, making it one of the most commonly reported side effect.
If you experience hypersensitivity while taking CEFUROXIME SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.